Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4135543Aexternal-prioritypatent/DE4135543A1/en
Application filed by Boehringer Mannheim GmbhfiledCriticalBoehringer Mannheim Gmbh
Publication of NO941544D0publicationCriticalpatent/NO941544D0/no
Publication of NO941544LpublicationCriticalpatent/NO941544L/en
En fremgangsmåte for produsering av rekombinant kjerne-streptavidin omfattende vetsceller som blir transformert med DNA kodende for kjerne-streptavidin, transformerte vertsceller blir dyrket under egnede betingelser og transformerte celler blir behandlet for å uttrykke DNA kodende for kjerne-streptavidin og for rekombinant kjerne-streptavidin blir isolert fra vertscellene eller dyrkningsmediet, er beskrevet. Anvendt som DNA kodende for kjerne-streptavidin er DNA som har (a) nukleotidsekvensen vist i SEQ ID NO. l eller (b) en nukleotidsekvens som tilsvarer sekvens (a) for degenerasjon av den genetiske koden.A method for producing recombinant nuclear streptavidin comprising tissue cells transformed with DNA encoding nuclear streptavidin, transformed host cells are cultured under appropriate conditions, and transformed cells are processed to express DNA encoding nuclear streptavidin and for recombinant nuclear streptavidin. isolated from the host cells or culture medium is described. Used as DNA encoding nuclear streptavidin is DNA having (a) the nucleotide sequence shown in SEQ ID NO. 1 or (b) a nucleotide sequence corresponding to sequence (a) for degeneration of the genetic code.